The Hope Difference

Hope-DifferenceTreating the whole person. Not only is it our mission, it’s what drives us every day. At Hope Cancer Care of Nevada, our patients receive the latest state-of-the-art cancer treatment along with a personally tailored program designed to put the body, mind and spirit at ease as it heals.

Our philosophy, which combines leading medical treatments with the ability to focus solely on their recovery. This approach allows our highly trained staff to craft individualized treatment programs for each patient.

Patient dignity and respect is foremost at Hope Cancer Care of Nevada. We take great measures to exceed your expectations and to be there for you, and your family, every step of the way.

slide_0

NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

09/06/17

Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of HPV vaccines. …read more Source:: Cancer


New Analysis Confirms Suspected Bias of Large U.S. Prostate Screening Study

09/05/17

By David Sampson A new paper appearing in Annals of Internal Medicine used simulation modeling to try to correct for a known bias in a notable U.S. trial of prostate cancer screening, called PLCO. That study along with a large … Read More


NCI study identifies essential genes for cancer immunotherapy

08/07/17

A new NCI study identifies genes in cancer cells that are necessary for them to be killed by T cells, and therefore could be partially responsible for why immunotherapy doesn’t work in some patients. …read more Source:: Cancer


NCI study shows feasibility of cancer screening protocol for patients with Li-Fraumeni syndrome

08/03/17

A new NCI study demonstrates the feasibility of a comprehensive screening protocol for patients with Li-Fraumeni syndrome, a rare inherited disorder that leads to a higher risk of developing certain cancers. …read more Source:: Cancer


NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers

07/24/17

The nationwide precision medicine trial will enroll children and adolescents with advanced cancers that haven’t responded to standard therapy to explore treatments targeted at specific genetic mutations. …read more Source:: Cancer


TCGA study of liver cancer reveals potential targets for therapy

06/15/17

Only two drugs are FDA-approved for liver cancer. This study of hepatocellular carcinoma found genetic alterations in tumors—including mutations in tumor-suppressing genes and high expression of immune checkpoint genes—that could be targets for drugs that already exist. …read more Source:: … Read More


Don’t Fry Day: Getting Sunscreen Right

05/25/17

By David Sampson Despite increased awareness about the dangers of ultraviolet (UV) radiation, melanoma rates continue to rise in the United States. For “Don’t Fry Day” on May 26, the American Cancer Society is cautioning that many people may be … Read More


Ventilated Filters: Changing the Face of Lung Cancer in the U.S.

05/23/17

By David Sampson An analysis appearing in the Journal of the National Cancer Institute finds strong evidence that adding ventilation holes to cigarette filters has contributed to a rise in a type of lung cancer called adenocarcinoma among smokers. The … Read More


Study estimates number of U.S. women living with metastatic breast cancer

05/18/17

A new study shows that the number of women in the United States living with distant metastatic breast cancer (MBC), the most severe form of the disease, is growing. This is likely due to the aging of the U.S. population … Read More


14: The Unmentioned Number in the Prostate Cancer/Coffee Story

05/05/17

By David Sampson Headlines across the Internet blared with the news over the past week that coffee could cut the risk of prostate cancer in half. It was an irresistible headline. But just how reliable was the finding? What if … Read More